171 related articles for article (PubMed ID: 29196028)
1. Serum Response Factor Promotes Dopaminergic Neuron Survival via Activation of Beclin 1-Dependent Autophagy.
Cheng XY; Li SY; Mao CJ; Wang MX; Chen J; Wang F; Wang GH; Deng WB; Li XK; Liu CF
Neuroscience; 2018 Feb; 371():288-295. PubMed ID: 29196028
[TBL] [Abstract][Full Text] [Related]
2. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of autophagy-related gene 5 (
Hu ZY; Chen B; Zhang JP; Ma YY
J Biol Chem; 2017 Nov; 292(44):18062-18074. PubMed ID: 28928221
[TBL] [Abstract][Full Text] [Related]
4. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.
Jalewa J; Sharma MK; Gengler S; Hölscher C
Neuropharmacology; 2017 May; 117():238-248. PubMed ID: 28223210
[TBL] [Abstract][Full Text] [Related]
5. Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death.
Wang YT; Lin HC; Zhao WZ; Huang HJ; Lo YL; Wang HT; Lin AM
Sci Rep; 2017 Apr; 7():45741. PubMed ID: 28401906
[TBL] [Abstract][Full Text] [Related]
6. Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation.
Ozbey G; Nemutlu-Samur D; Parlak H; Yildirim S; Aslan M; Tanriover G; Agar A
Pharmacol Rep; 2020 Oct; 72(5):1397-1406. PubMed ID: 32207092
[TBL] [Abstract][Full Text] [Related]
7. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
[TBL] [Abstract][Full Text] [Related]
8. Apelin-13 Protects Dopaminergic Neurons against Rotenone-Induced Neurotoxicity through the AMPK/mTOR/ULK-1 Mediated Autophagy Activation.
Chen P; Wang Y; Chen L; Song N; Xie J
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171641
[TBL] [Abstract][Full Text] [Related]
9. Ablation of serum response factor in dopaminergic neurons exacerbates susceptibility towards MPTP-induced oxidative stress.
Rieker C; Schober A; Bilbao A; Schütz G; Parkitna JR
Eur J Neurosci; 2012 Mar; 35(5):735-41. PubMed ID: 22356487
[TBL] [Abstract][Full Text] [Related]
10. VGLUT2 Is a Determinant of Dopamine Neuron Resilience in a Rotenone Model of Dopamine Neurodegeneration.
Buck SA; De Miranda BR; Logan RW; Fish KN; Greenamyre JT; Freyberg Z
J Neurosci; 2021 Jun; 41(22):4937-4947. PubMed ID: 33893220
[TBL] [Abstract][Full Text] [Related]
11. Dopamine neuron loss by selective deletion of autophagy-related gene 5 is not exacerbated by MPTP toxicity in midbrain.
Ren YH; Niu XY; Huang HJ; Hao XD; Wang PX; Chi YL; Ding YQ; Liao M
Neurosci Lett; 2018 May; 675():140-144. PubMed ID: 29175031
[TBL] [Abstract][Full Text] [Related]
12. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
[TBL] [Abstract][Full Text] [Related]
13. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA
J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822
[TBL] [Abstract][Full Text] [Related]
14. Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models.
Liu J; Liu W; Lu Y; Tian H; Duan C; Lu L; Gao G; Wu X; Wang X; Yang H
Autophagy; 2018; 14(5):845-861. PubMed ID: 29433359
[TBL] [Abstract][Full Text] [Related]
15. Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease.
Kang SY; Lee SB; Kim HJ; Kim HT; Yang HO; Jang W
Neurosci Lett; 2017 Mar; 642():20-26. PubMed ID: 28137648
[TBL] [Abstract][Full Text] [Related]
16. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.
Sherer TB; Kim JH; Betarbet R; Greenamyre JT
Exp Neurol; 2003 Jan; 179(1):9-16. PubMed ID: 12504863
[TBL] [Abstract][Full Text] [Related]
18. Flavin-containing monooxygenase, a new clue of pathological proteins in the rotenone model of parkinsonism.
Li B; Yuan Y; Zhang W; He W; Hu J; Chen N
Neurosci Lett; 2014 Apr; 566():11-6. PubMed ID: 24440618
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of bcl-2 enhanced rotenone-induced α-synuclein aggregation associated with autophagic pathways.
Chen Y; Zhang N; Ji D; Hou Y; Chen C; Fu Y; Ge R; Zheng Q; Chen J; Wang H
Neuroreport; 2018 Sep; 29(14):1201-1208. PubMed ID: 30059366
[TBL] [Abstract][Full Text] [Related]
20. SLC35D3 increases autophagic activity in midbrain dopaminergic neurons by enhancing BECN1-ATG14-PIK3C3 complex formation.
Wei ZB; Yuan YF; Jaouen F; Ma MS; Hao CJ; Zhang Z; Chen Q; Yuan Z; Yu L; Beurrier C; Li W
Autophagy; 2016 Jul; 12(7):1168-79. PubMed ID: 27171858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
